UWM+ Rebopharm Arzneimittelvertriebsgesellschaft mbH (Q3434087): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Process consulting, which supports the establishment of an in-house learning and experimentation space in the company and thus initiates and accompanies an in-house learning and development process., translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
UWM+ Rebopharm Arzneimittelvertriebsgesellschaft mbH | |||
Revision as of 10:09, 16 November 2021
Project Q3434087 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | UWM+ Rebopharm Arzneimittelvertriebsgesellschaft mbH |
Project Q3434087 in Germany |
Statements
14 November 2018
0 references
5 February 2019
0 references
Rebopharm Arzneimittelvertriebsgesellschaft mbH
0 references
51°49'9.88"N, 6°35'23.14"E
0 references
46395
0 references
Prozessberatung, die die Etablierung eines betrieblichen Lern- und Experimentierraums im Unternehmen unterstützt und so einen betrieblichen Lern- und Entwicklungsprozess initiiert und begleitet. (German)
0 references
Process consulting, which supports the establishment of an in-house learning and experimentation space in the company and thus initiates and accompanies an in-house learning and development process. (English)
16 November 2021
0 references
Nordrhein-Westfalen
0 references
Identifiers
DE_TEMPORARY_ESF_30534
0 references